You are viewing: Europe ECMO Machines Market analysis
Part of: ECMO Machines Market (Global)

The Europe ECMO Machines Market was valued at $11.57 Million in 2025 and projected to reach to $16.93 Million by 2030, representing a compound annual growth rate of 7.9%. Europe's ECMO machines market is positioned for sustained growth through 2030, driven by an aging demographic requiring advanced cardiac interventions and rising incidence of respiratory complications.

Europe ECMO Machines Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Europe ECMO Machines Market Trends and Insights

  • This represents a compound annual growth rate (CAGR) of 7.9%, significantly outpacing global market trends.
  • GCC Countries are increasingly investing in advanced cardiac and respiratory support technologies, driven by rising healthcare expenditure and improved access to critical care infrastructure across the region. GCC Countries' ECMO market expansion is fueled by growing prevalence of cardiovascular and respiratory diseases, coupled with enhanced hospital capabilities and clinical adoption of extracorporeal membrane oxygenation therapies.
  • Between 2025 and 2030, GCC Countries are expected to strengthen their position as a key regional hub for advanced medical device deployment.
  • The region's focus on healthcare modernization and patient outcomes is positioning GCC Countries as an attractive market for ECMO machine manufacturers and healthcare providers seeking to expand their critical care offerings..

Key Market Statistics

  • CAGR (2025-2030) 7.9% CAGR
  • Market Size, 2025 ~USD 11.57 Million
  • Forecast, 2030 ~USD 16.93 Million
  • Geography Europe

Europe ECMO Machines Market Overview

Market Leadership :

Europe commands a significant share of the global ECMO machines market, with Germany leading at USD 25.73 million, followed by the UK at USD 24.96 million, demonstrating strong adoption of advanced cardiac support technologies across major healthcare systems.

Robust Regional Growth :

The European ECMO market is expanding at a CAGR of 7.9%, substantially exceeding the global growth rate of 5.8%, driven by aging populations, increased prevalence of cardiac diseases, and substantial healthcare infrastructure investments.

Diverse Market Composition :

Europe's ECMO market spans multiple developed economies including France (USD 20.84 million), Italy (USD 16.63 million), and Spain (USD 16.14 million), with Rest of Europe contributing USD 180 million, reflecting widespread market penetration across the continent.

Clinical Adoption Acceleration :

European hospitals are increasingly integrating ECMO technology for complex cardiac and respiratory cases, supported by favorable reimbursement policies, advanced medical infrastructure, and growing clinical evidence supporting improved patient outcomes.

Europe ECMO Machines Market Dynamics

  • Major European healthcare systems are prioritizing investment in extracorporeal membrane oxygenation technology to enhance critical care capabilities and improve survival rates in severe cardiac and pulmonary conditions. The region benefits from strong regulatory frameworks, established reimbursement mechanisms, and a concentration of leading medical device manufacturers.
  • Continued innovation in portable and miniaturized ECMO systems, combined with expanding clinical applications beyond traditional cardiac surgery, will further accelerate market expansion across Western and Eastern European markets..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • GCC Countries ECMO market valued at USD 11.57 million in 2025, growing at 7.9% CAGR through 2030
    • GCC Countries demonstrate strong healthcare infrastructure investment supporting ECMO technology adoption
    • Rising cardiovascular and respiratory disease prevalence in GCC Countries drives critical care demand
    • GCC Countries positioned as regional leader for advanced extracorporeal membrane oxygenation deployment

    ECMO Machines Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR) (Application)
    Forecast Period 2025–2030
    Growth Rate CAGR of 5.8% from 2025 to 2030
    Largest Segment ADULT PATIENTS (Patient Type)
    Market Size Base Year (Billions) ~USD 0.65 (2025)
    Revenue Forecast (Billions) ~USD 0.86 (2030)
    Segments Covered Product, Type, Modality, Patient Type, Application, End User

    Europe ECMO Machines Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Product

    • Components
    • Machines

    By Type

    • Accessories
    • Cannulas
    • Controllers
    • Oxygenators
    • Pumps

    By Modality

    • Arteriovenous Ecmo
    • Venoarterial Ecmo
    • Venovenous Ecmo

    By Patient Type

    • Adult Patients
    • Neonates
    • Pediatric Patients

    By Application

    • Cardiac Applications
    • Extracorporeal Cardiopulmonary Resuscitation (Ecpr)
    • Respiratory Applications

    By End User

    • Academic & Research Institutions
    • Hospitals
    • Specialty Clinics

    EUROPE: ECMO MACHINES MARKET, BY END USER, 2023–2030

    Segment20232024202520262027202820292030CAGR (%)
    ACADEMIC & RESEARCH INSTITUTIONS29.5130.6431.8733.1834.6336.2237.9539.824.6
    HOSPITALS116.33121.94128.06134.61141.89149.82158.49167.955.6
    SPECIALTY CLINICS20.4821.0621.722.3823.1523.9824.8925.883.6
    TOTAL166.32173.63181.63190.17199.67210.02221.32233.655.2

    REST OF EUROPE: ECMO MACHINES MARKET, BY END USER, 2023–2030

    Segment20232024202520262027202820292030CAGR (%)
    ACADEMIC & RESEARCH INSTITUTIONS8.028.358.719.19.539.9910.511.064.9
    HOSPITALS33.7435.4637.3539.3741.6144.0646.7449.675.9
    SPECIALTY CLINICS5.625.85.996.26.436.696.967.263.9
    TOTAL47.3749.6152.0554.6757.5760.7464.267.985.5

    Target Audience

    • Medical Device Manufacturers : ECMO device manufacturers need Europe-specific market data to develop localized product strategies, identify distribution partnerships, and optimize pricing for competitive European markets.
    • Healthcare Investors & PE Firms : Investment professionals require detailed European market analysis to evaluate acquisition targets, assess growth potential, and make informed capital allocation decisions in the critical care segment.
    • Hospital & Healthcare Systems : European hospital networks need market intelligence to benchmark ECMO adoption rates, justify capital expenditures, and develop procurement strategies aligned with clinical demand.
    • Regulatory & Compliance Consultants : Consultants supporting market entry require country-specific regulatory requirements, reimbursement landscapes, and compliance frameworks to guide clients through European commercialization.
    • Market Research & Strategy Teams : Corporate strategy and business development teams need comprehensive European market data to support competitive analysis, market sizing, and long-term strategic planning in critical care technologies.

    Key Companies in the Europe ECMO Machines Market

    CompanyHQOwnershipStrongest segments
    GETINGESwedenPublic CompanyAcute Care Therapies,Surgical Workflows,Life Science,
    MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes),
    TERUMO CORPORATIONJapanPublic CompanyCardiac and Vascular Company,Medical Care Solutions Company,Blood and Cell Technologies Company,
    FRESENIUS MEDICAL CARE AGGermanyPublic CompanyDialysis services (outpatient and in-hospital ESRD/acute),Dialysis machines, cyclers, and water treatment systems,Dialysis consumables and solutions,
    LIVANOVA PLCUnited KingdomPublic CompanyCardiopulmonary (heart-lung machines, oxygenators, autotransfusion, perfusion tubing, cannula, services),Neuromodulation (VNS Therapy for epilepsy and depression, aura6000 development),
    NIPROJapanPublic CompanyDialysis products and artificial organ-related devices,Injection and infusion products, hospital and diabetic products, functional products,Pharmaceutical-Related (CDMO for injectables and oral drugs, kit products),
    WEIGAO GROUP CO., LTD.ChinaPublic CompanyMedical Device Products (infusion, clinical nursing, perioperative, urinary, rehab, extracorporeal circulation),Orthopedic Products (spine, joint, trauma, sports medicine, bone repair, spinal endoscope),Pharma Packaging Products (prefilled systems, packaging consumables, automatic drug delivery),
    ABBOTTUnited StatesPublic CompanyDiagnostic Products,Medical Devices,Nutritional Products,
    MICROPORT SCIENTIFIC CORPORATIONChinaPublic CompanyCardiovascular Devices,Orthopedics Devices,Cardiac Rhythm Management,

    GETINGE

    Getinge is a Swedish public company founded in 1904 that employs 11,754 people and operates in the medical technology sector.

    MEDTRONIC

    Medtronic is a public company headquartered in Ireland, founded in 1949, with approximately 95,000 employees specializing in medical devices and healthcare solutions.

    TERUMO CORPORATION

    Terumo Corporation is a Japanese public company established in 1921 with 30,591 employees, operating in the medical device and healthcare industry.

    FRESENIUS MEDICAL CARE AG

    Fresenius Medical Care AG is a German public company founded in 1996 with 108,165 employees, providing dialysis and renal care services globally.

    LIVANOVA PLC

    LivaNova PLC is a United Kingdom-based public company founded in 2015 with 3,300 employees, focused on neuromodulation and cardiac surgery solutions.

    NIPRO

    Nipro is a Japanese public company established in 1947 with 38,593 employees, manufacturing medical devices and pharmaceutical products.

    WEIGAO GROUP CO., LTD.

    Weigao Group Co., Ltd. is a Chinese public company founded in 1988 with 13,307 employees, specializing in medical device manufacturing.

    ABBOTT

    Abbott is a United States-based public company founded in 1888 with 115,000 employees, operating across diagnostics, medical devices, nutrition, and pharmaceuticals.

    MICROPORT SCIENTIFIC CORPORATION

    MicroPort Scientific Corporation is a Chinese public company established in 1998 with 6,547 employees, developing and manufacturing medical devices.

    Europe vs. other regions

    HowEurope compares to the other 3 regional blocs covered in this market.

    Global
    ~USD 343 Million · 5.6% wtd CAGR ·
    North America
    ~USD 233.7 Million · 5.2% wtd CAGR ·
    Asia Pacific
    ~USD 20.28 Million · 6.9% wtd CAGR ·
    Middle East & Africa
    ~USD 65.7 Million · 6% wtd CAGR ·

    Countries within Europe - compare and drill down

    Country2025 size (native)
    GermanyUSD 25.73 Million
    FranceUSD 20.84 Million
    UKUSD 24.96 Million
    ItalyUSD 16.63 Million
    SpainUSD 16.14 Million
    Rest of EuropeUSD 180 Million

    Country market size visualization

    Germany
    USD 25.73 Million
    France
    USD 20.84 Million
    UK
    USD 24.96 Million
    Italy
    USD 16.63 Million
    Spain
    USD 16.14 Million
    Rest of Europe
    USD 180 Million

    Reasons to Buy this Report

    • Country-Level Market Insights : Gain detailed market sizing and growth projections for key European markets including Germany, UK, France, Italy, and Spain, enabling targeted market entry and expansion strategies.
    • Competitive Landscape Analysis : Understand market dynamics, competitive positioning, and key players operating across Europe's fragmented ECMO market to identify partnership and acquisition opportunities.
    • Regulatory & Reimbursement Framework : Access comprehensive analysis of European regulatory pathways, CE marking requirements, and country-specific reimbursement policies affecting ECMO device commercialization.
    • Clinical Adoption Trends : Identify emerging clinical applications, hospital adoption rates, and physician preferences across European healthcare systems to optimize product positioning and marketing strategies.
    • Growth Opportunity Mapping : Discover high-growth segments, underserved markets, and emerging opportunities within Rest of Europe to prioritize resource allocation and market development initiatives.

    Frequently asked questions

    What is the current market size of ECMO machines in GCC Countries?

    The ECMO Machines Market in GCC Countries was valued at USD 11.57 million in 2025 and is expected to reach USD 16.93 million by 2030.

    What is the projected growth rate for ECMO machines in GCC Countries?

    GCC Countries' ECMO market is projected to grow at a compound annual growth rate (CAGR) of 7.9% from 2025 to 2030.

    What factors are driving ECMO market growth in GCC Countries?

    Key drivers include rising healthcare expenditure, increased prevalence of cardiovascular and respiratory diseases, improved hospital infrastructure, and growing clinical adoption of extracorporeal membrane oxygenation therapies in GCC Countries.

    How does GCC Countries' ECMO market compare to global trends?

    GCC Countries' ECMO market CAGR of 7.9% significantly outpaces the global market CAGR of 5.8%, indicating stronger regional growth momentum.

    What is the forecast market size for ECMO machines in GCC Countries by 2030?

    The ECMO Machines Market in GCC Countries is forecasted to reach USD 16.93 million by 2030, representing a growth of USD 5.36 million from 2025 levels.

    RESEARCH METHODOLOGY

    The study involved major activities in estimating the current market size of the ECMO machines market. Exhaustive secondary research was done to collect information on the ECMO market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the ECMO market.

    Secondary Research

    This research study involved the wide use of secondary sources, directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, Factiva, whitepapers, and companies’ house documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the ECMO market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various supply- and demand-side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, engineers, and related key executives from various companies and organizations operating in the ECMO market. Primary sources from the demand side included hospitals, academic & research institutions, specialty clinics, researchers, lab technicians, purchase managers, and stakeholders in corporate & government bodies.

    The following is a breakdown of the primary respondents:

    ECMO Machines Market

    Note 1: C-level primaries include CEOs, COOs, and CTOs.

    Note 2: Others include sales managers, marketing managers, and product managers.

    Note 3: Companies are classified into tiers based on their total revenue. As of 2024: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3=< USD 500 million

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the ECMO market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    ECMO Machines Market

    Data Triangulation

    The entire market was split into three segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the entire market engineering process and arrive at precise statistics for all segments.

    Approach to derive the market size and estimate market growth.

    Using secondary data from paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of ECMO machines and components. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.

    Market Definition

    An ECMO machine acts as an artificial heart and lung for a patient whose heart or lungs cannot provide enough blood flow or oxygen into the blood. ECMO is used after other methods of supporting the heart and lungs do not work. The goal of ECMO is to let the heart and lungs recover while the patient is supported by the ECMO machine.

    Stakeholders

    • Manufacturers of ECMO Machine Products and Related Devices
    • Suppliers and Distributors of ECMO Machine Devices
    • Hospitals, Clinics, and Medical Colleges
    • Medical Device Procurement Agencies
    • Government Bodies/Municipal Corporations
    • Business Research and Consulting Service Providers
    • Venture Capitalists
    • US Food and Drug Administration (US FDA)
    • European Union (EU)

    Report Objectives

    • To define, describe, and forecast the oxygen concentrators market based on product, modality, patient type, application, end user, and region  
    • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall oxygen concentrators market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the oxygen concentrators market in six regions, namely, North America (US and Canada), Europe (Germany, UK, France, Spain, Italy, and Rest of Europe), the Asia Pacific (Japan, China, India, Australia, South Korea, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), Middle East & Africa, and GCC Countries
    • To strategically profile the key players in the global market and comprehensively analyze their core competencies
    • To track and analyze competitive developments, such as product launches, expansions, agreements, and acquisitions, of the leading players in the market

    Get the Full ECMO Machines Market Report

    Full forecast, segment splits, and company analysis for all ECMO Machines Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status